Phase 1b/2 KEYNOTE-365 Cohort I: Pembrolizumab (Pembro) plus Carboplatin and Etoposide Chemotherapy (Chemo) or Chemo Alone for Metastatic Neuroendocrine Prostate Cancer (NEPC)
| dc.contributor.author | Gonzalez-Billalabeitia, Enrique | |
| dc.contributor.author | Von Amsberg, Gunhild | |
| dc.contributor.author | Arslan, Cagatay | |
| dc.contributor.author | Mehra, Niven | |
| dc.contributor.author | Emmenegger, Urban | |
| dc.contributor.author | Robbrecht, Debbie G. J. | |
| dc.contributor.author | Yu, Evan Y. | |
| dc.date.accessioned | 2026-03-27T13:42:17Z | |
| dc.date.available | 2026-03-27T13:42:17Z | |
| dc.date.issued | 2025 | |
| dc.description.sponsorship | Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA | |
| dc.identifier.doi | 10.1200/JCO.2025.43.16_suppl.5059 | |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.issn | 1527-7755 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14365/8866 | |
| dc.identifier.uri | https://doi.org/10.1200/JCO.2025.43.16_suppl.5059 | |
| dc.language.iso | en | |
| dc.publisher | Lippincott Williams & Wilkins | |
| dc.relation.ispartof | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 30-JUN 03, 2025 -- Chicago, IL | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.title | Phase 1b/2 KEYNOTE-365 Cohort I: Pembrolizumab (Pembro) plus Carboplatin and Etoposide Chemotherapy (Chemo) or Chemo Alone for Metastatic Neuroendocrine Prostate Cancer (NEPC) | |
| dc.type | Conference Object | |
| dspace.entity.type | Publication | |
| gdc.author.wosid | Gonzalez-Billalabeitia, Enrique/ABG-4621-2020 | |
| gdc.author.wosid | Mosca, Alessandra/O-7975-2016 | |
| gdc.description.department | İzmir University of Economics | |
| gdc.description.departmenttemp | Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; Sunnybrook Res Inst, Toronto, ON, Canada; Erasmus MC Canc Inst, Rotterdam, Netherlands; Izmir Univ Econ, Med Point Hosp, Izmir, Turkiye; Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands; Hosp Univ 12 Octubre, Madrid, Spain; Szpital Wojewodzki Im Mikolaja Kopern, Koszalin, Poland; Tech Univ Munich, Rechts Isar Med Ctr, Munich, Germany; Baskent Univ, Adana Dr Turgut Noyan Applicat & Res Ctr, Adana, Turkiye; Univ Coll London UCL Hosp, London, England; UCL Canc Inst, London, England; Ctr Eugene Marquis, Rennes, France; Candiolo Canc Inst FPO IRCCS, Turin, Italy; Hosp Civil Guadalajara Fray Antonio Alcalde, Guadalajara, Mexico; West Canc Ctr & Res Inst, Germantown, TN USA; Cleveland Clin, Taussig Canc Ctr, Cleveland, OH USA; Ctr Oncol Int, Mexico City, Mexico; MSD China Co Ltd, Beijing, Peoples R China; Merck & Co Inc, Rahway, NJ USA; Univ Washington, Fred Hutchinson Canc Ctr, Seattle, WA USA | |
| gdc.description.endpage | 5059 | |
| gdc.description.issue | 16_SUPPL | |
| gdc.description.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
| gdc.description.startpage | 5059 | |
| gdc.description.volume | 43 | |
| gdc.description.woscitationindex | Science Citation Index Expanded - Conference Proceedings Citation Index - Science | |
| gdc.identifier.wos | WOS:001690385700023 | |
| gdc.index.type | WoS | |
| gdc.virtual.author | Arslan, Çağatay | |
| relation.isAuthorOfPublication | e39c1203-60be-410a-97b3-27cb69d126a9 | |
| relation.isAuthorOfPublication.latestForDiscovery | e39c1203-60be-410a-97b3-27cb69d126a9 | |
| relation.isOrgUnitOfPublication | 7b4bd652-27ef-4beb-a10e-dddd2d65e0fd | |
| relation.isOrgUnitOfPublication | fbc53f3e-d1d3-4168-afd8-e42cd20bddd9 | |
| relation.isOrgUnitOfPublication | e9e77e3e-bc94-40a7-9b24-b807b2cd0319 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 7b4bd652-27ef-4beb-a10e-dddd2d65e0fd |